High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia

Pediatric MLL-rearranged acute myeloid leukemia (AML) has a generally unfavorable outcome, primarily due to relapse and drug resistance. To overcome these difficulties, new therapeutic agents are urgently needed. Yet, implementing novel drugs for clinical use is a time-consuming, laborious, costly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wander, Priscilla, Arentsen-Peters, Susan T.C.J.M., Pinhanҫos, Sandra S., Koopmans, Bianca, Dolman, M.Emmy M., Ariese, Rijndert, Bos, Frank L., Castro, Patricia Garrido, Jones, Luke, Schneider, Pauline, Navarro, Miriam Guillen, Molenaar, Jan J., Rios, Anne C., Zwaan, C. Michel, Stam, Ronald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933809/
https://www.ncbi.nlm.nih.gov/pubmed/33667892
http://dx.doi.org/10.1016/j.tranon.2021.101048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933809/
https://www.ncbi.nlm.nih.gov/pubmed/33667892
http://dx.doi.org/10.1016/j.tranon.2021.101048

Ejemplares similares